Spatiotemporal specificity of H3 receptor signaling: from molecular basis to precise regulation of brain function

The histamine H3 receptor (H3R) is widely distributed throughout the brain, where it controls histamine release and influences other neurotransmitter systems. Therefore, it has been considered a promising drug target for conditions like narcolepsy, ADHD, schizophrenia, and obesity. Yet after decades of effort and many clinical trials, drugs that act on this receptor have produced only modest and inconsistent results. In this review, we argue that this gap lies in the spatiotemporal complexity of H3R functions. H3R signaling depends on multiple factors: which splice variant is expressed, whether the receptor is located pre- or postsynaptically, which brain region or circuit it operates in, whether the tissue is healthy or diseased, and how the ligand binds to it. We summarize recent advances in understanding H3R structure, biased signaling, optogenetic and photopharmacological tools, and strategies for delivering drugs to specific cell types. We also discuss emerging approaches that combine brain imaging with gene expression data to identify biomarkers for patient selection. Collectively, we propose that realizing the therapeutic potential of H3R will require a paradigm shift from systemic modulation to spatiotemporally precise intervention, grounded in the spatiotemporal complexity of H3R functions.